lancet semaglutide Efficacy and safety of once-weekly monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial Use of new diet drugs

Weve handled claims against medical and hospital negligence, personal injury claims, and more

Manufacturers are reaping the benefits from soaring demand for Ozempic, Wegovy, and other GLP-1 prescription drugs for weight loss

6 Some reviews suggest GLP-1s may even offer comparable or slightly better muscle preservation than diet-only approaches

Increased competition Novo Nordisk has faced challenges as sales of Wegovy and diabetes treatment medication Ozempic begin to lose momentum, particularly in the United States

Ongoing Monitoring and Support Patients receive continued check-ins, progress monitoring, and care plan adjustments throughout the program under licensed provider oversight

It is not known if semaglutide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people